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Abstract 
Background: This study was aimed to silencing the Nucleoside transporter 3 (NT3) 
permease nucleobases involved in the salvage pathway of Leishmania in order to disrupt 
purine nucleotide uptake in the parasite and consequently, destruction of the parasite. 
Methods: Overall, 502 bp fragment of the NT3 gene sequence was designed to pro-
duce an antisense transcript upon entry of the vector into the parasite. The NT3 con-
struct was transfected into L. major promastigotes and NT3 gene expression was stud-
ied in vivo and in vitro conditions. 
Results: Relative expression NT3 gene in transgenic Leishmania was decreased in tenth 
day. The percentages and the number of amastigotes infected macrophages with trans-
genic L. major were less than infected macrophages with wild-type strain. Our results in 
two groups of BALB/c female mice (wild-type strain and mutant, n=4 each group) 
were showed that size and number of ulcers in BALB/c mice infected with transgenic 
Leishmania promastigotes were less than the BALB/c mice infected with wild-type para-
sites. 
Conclusion: The results indicate the use of antisense RNA reduces of NT3 gene ex-
pression in L. major. More studies are required to obtain a new approach for treating 
Leishmania infection. 
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Introduction 
 
eishmaniasis is a disease with a broad 
range of clinical manifestations 
caused by several species of the ge-
nus Leishmania, in the family Trypanosomatidae 
(1, 2). It is one of the most important parasit-
ic diseases in 98 countries and manifests in 
cutaneous, visceral and cutaneous-mucosal 
forms (3). The life cycle of these parasites has 
two stages: amastigote that resides inside the 
reticuloendothelial cells of the vertebrate host 
and a slender, promastigote that replicates in 
medium and in the gut of the sandfly as a bio-
logical vector (1). Like all protozoa, Leishma-
nia spp. are unable to synthesize cyclic purines 
de novo and must import purines from both 
their vertebrate and insect hosts (4, 5). In all 
organisms, purines are responsible for many 
vital functions, like the synthesis of DNA and 
RNA as well as precursors of coenzyme A, 
ATP, GTP, NADH, carbohydrates, lipids and 
the second messenger cAMP (6, 7). All para-
site purine transporters are members of the 
Equilibrative Nucleoside Transporter SLC29 
family in the human genome database (8, 9) 
or the 2.A57 family in the transporter classifi-
cation database (10). Nucleoside transporters 
are present in mitochondria, cell membranes 
and lysosomes. Leishmania absorbs purines via 
purine permease through food and salvage. 
The first step of salvage is the displacement 
of purine nucleosides and nucleobases in the 
plasma membrane of the parasite. These hy-
drophilic nucleosides and nucleobases are un-
able to be released in the parasitic plasma 
membrane lipid layers, and proteins or trans-
porters are needed to move them. The purine 
transporters are pharmacologically critical, as 
well as being important in human 
pathogenesis because they act as mediators in 
purine analogue uptake. Non-purine drugs 
such as allopurinol, which is an anti-
Leishmania drug, are toxic to parasites when 
they enter into these organisms via purine 
transporters (4, 6, 7, 11, 12).  
The Leishmania genome has four identified 
sites for purine transfer, known as nucleoside 
transporters 1–4 (NT1, NT2, NT3 and NT4) 
(6). Leishmania major expresses two purine nu-
cleobase transporters, nucleoside transporters 
3 and 4 (NT3 and NT4). Functional analysis 
of cloned transporter genes has revealed that 
purine nucleobases, including adenine, gua-
nine, hypoxanthine and xanthine, are the spe-
cific targets of NT3 (6, 13, 14). NT3 per-
mease expresses a large quantity of mRNA 
during the growth of parasites and has a high 
affinity for purine nucleobases. Although 
NT3 permease nucleobases are not essential 
for the parasite, NT3 gene deletion may re-
duce parasite viability and lead to the death of 
the parasite. These events underline the es-
sential role of nucleobase transporters of 
Leishmania in purine uptake in both vertebrate 
and invertebrate hosts (14).  
For this reason, this research was carried 
out to knocking-down the NT3 permease nu-
cleobases that are involved in the salvage 
pathway of Leishmania in order to disrupt pu-
rine nucleotide uptake in the parasite, result-
ing in the death of the parasite. 
 
Materials and Methods 
 
NT3 plasmid construct  
The 502 bp sequence (5′ end) of NT3 gene 
(Accession Number: XM_ 001681813) was 
considered as antisense. This antisense was 
synthesized by Generay Technology, Shanghai 
Co, China. Gene was subcloned into pcDNA 
3.1 Neomycin vector by Hind III and EcoRI 
restriction enzymes. E. coli strain TOP 10 was 
selected and recombinant plasmid was trans-
formed into it. Subsequently, plasmid was ex-
tracted and confirmed by Hind III and EcoRI 
restriction analysis. Presence of NT3 gene was 
confirmed by PCR method with following 
primers: 
L 
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F: 5΄- GGCGTACCTCTACTTCAGCC-3΄, R: 
5΄- TTGATGGCACGGTACTCACC-3΄. 
 
Culture of Leishmania major 
L. major promastigotes (MRHO/IR/75/ER) 
were grown in complete DMEM culture me-
dium containing 10% inactivated foetal bovine 
serum and 100U/ml penicillin and 100 μg/ml 
streptomycin and incubated at 25 °C. After 
24–48 h, the cells were used for electro-
poration (15). 
 
Transfection 
L. major promastigotes at stationary phase 
with concentration of 1 × 106/ml were 
washed in PBS buffer and resuspended in 
electroporation buffer (20mM HEPES, pH 
7.2, 137mM NaCl, 5 mM KCl, 0.7 mM 
Na2HPO4, and 6mM Glucose). Overall, 350 μl 
promastigotes were transferred to a 0.2 cm 
electroporation cuvette (Eppendorf, Germa-
ny) containing 2 ng/μl plasmid DNA 
harbouring the antisense NT3 gene. Electro-
poration was performed at 1000 V with a ca-
pacitance of 160 μs. Transfected cells were 
incubated on ice for 10 min, then transferred 
to 2 ml complete DMEM medium without 
antibiotics, and finally incubated at 25 °C for 
20-24 h. On the second day, after centrifuga-
tion of cell cultures and removal of the super-
natant, the precipitate was dissolved in the 
suspension obtained and transferred into 1cc 
complete DMEM medium containing 50 
μg/ml G418 antibiotics (Sigma, USA) and in-
cubated at 25 ºC. This culture medium was 
checked every day for cell number, morpholo-
gy and motility under a microscope (15-17). 
Wild-type L. major as positive control was 
electroporated.  
 
Quantitative real time-RT PCR 
Total RNA was extracted from the mutant 
and wild-type promastigotes on 3, 7, 10, 15 
and 20 d after transfection by total RNA Puri-
fication kit (Jena Bioscience, Germany). The 
cDNA synthesized was performed using Ac-
cuPower RT PreMix (Bioneer, Korea). The 
rRNA 45 gene of L. major was used as a 
housekeeping gene (18). The following PCR 
cycling conditions: denaturation 55 °C for 30 
sec; amplification for 12 cycles of 20 °C (30 
sec), 42 °C (4 min) and 95 °C (5 min). Real-
time PCR was performed with 1 μl of cDNA, 
2 μl of 5 pmol primers and 5 μl 2 × Greenstar 
qPCR Master Mix (Bioneer, Korea) and 2 μl 
of deionized water in a final volume of 10 μl. 
The real-time PCR program in the Rotor gene 
6000 (Qiagen, USA) was as follows: 94 °C for 
2 min and 94 °C for 20 sec; 40 cycles of 53 °C 
for 20 sec and 72 °C for 30 sec. Relative quan-
tity (RQ) values were calculated using the 2 –
ΔΔCt method. 
  
Western blot analysis 
Pellets of mutant and wild-type Leishmania 
promastigotes (after transfection) were col-
lected by centrifugation on day 3, 7, 10, 15 and 
20; proteins were extracted into lysis buffer 
and separated by SDS-PAGE in 10% acryla-
mide gel (19). The protein bands were trans-
ferred to a nitrocellulose membrane. NT3-
specific sheep antibody was used as a primary 
antibody with titer of 1:1000 (Genscript, USA). 
Rabbit anti-sheep IgG antibody conjugated 
with alkaline phosphatase (as a 1:10000 dilu-
tion) was used for the detection of NT3 pro-
tein. 
 
Macrophage infection assay 
The murine macrophages cell line J774 were 
cultured at a concentration of 2 × 105 in 
RPMI-1640 containing 10% inactivated FBS, 
100 U/ml penicillin and 100 μg/ml strepto-
mycin in Nunc 24-well plates. These plates 
were incubated at 37 °C with 5% CO2 (20). 
After five h, the culture medium was changed. 
Then, 24 h later, 1 × 106 transgenic L. major 
promastigotes and wild-type L. major pro-
mastigotes were added into the Nunc® 24-well 
plates containing cell line J774. The plates 
were incubated at 37 °C with 5% CO2 (20). 
Two smears were prepared from the plates 
after 24, 48 and 72 h and Giemsa staining 
were performed. In each smear, the percent-
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age of infected macrophages and the mean 
number of amastigotes per infected macro-
phages in one hundred macrophages were cal-
culated. The number of amastigotes in macro-
phages and the percentage of infected macro-
phages were counted.  
 
Infectivity in BALB/c mice 
Two groups (n = 4) of BALB/c female mice 
(4–6 wk of age), 20-25 gr and were used. Mice 
of one group were infected with wild-type and 
another group were infected with mutant 
promastigotes. Mice for macroscopic exami-
nation with respect to ulcer(s) incubation pe-
riod; count and diameter form each group was 
studied. Wild-type and transgenic pro-
mastigotes a concentration of 1.5 × 108 (21) 
were injected subcutaneously into the base of 
the tails of mice in a 0.1 ml volume (22). The 
mice were examined macroscopically for 4 wk 
after infection.  
 
Ethics Statements 
The Ethics Committee on Laboratory Ani-
mals at Kerman University of Medical Scienc-
es (KMU) approved the study protocols of 
this project (Code of Number ethics: 92/78, 
2013). This research was performed in com-
pliance with the recommendations and guide-
lines for the use and surveillance of laboratory 
animals of International Institute. Neverthe-
less, all efforts were made to minimize animal 
suffering.  
 
Statistical analysis  
Data analysis was performed using SPSS 
version 22.0 (SPSS Inc., Chicago, IL, USA) 
and ANOVA was used for statistically signifi-
cant differences (P<0.05). 
 
Results 
 
NT3 fragment antisense was cloned in 
pcDNA 3.1 Neomycin+ vector. By using 
NT3-specific primers, PCR was performed 
and the 500-bp cloned fragment was isolated. 
 
NT3 gene expression 
Real time-RT PCR results analysis on days 3, 
7, 10, 15 and 20 after transfection revealed 
that NT3 gene expression in transgenic Leish-
mania was reduced on the tenth day, but it had 
upward trend up to the twentieth day. There 
was a significant difference in increased ex-
pression of this gene on day 7 and reduction 
of its expression on tenth day in mutant para-
site (P<0.05) (Fig. 1). 
 
NT3 protein identity by Western blotting  
NT3 gene in transgenic Leishmania was ex-
pressed on 20, 15, and 10 d (Fig 2) and its ex-
pression was too low (Fig. 3). 
 
 
 
Fig. 1: NT3 gene expression in mutant Leishmania major on 3, 7, 10, 15 and 20 d post electroporation. Real 
time-RT PCR results analysis revealed that NT3 gene expression in transgenic Leishmania was at 3 d: 
0.875±0.832201825 (P<0.85), 7 day: 1.439±0.035264924 (P<0.003), 10 d: 0.596±0.228100628 (P<0.01), 15 d: 
1.00±1.73422E-15 (P<0.39), and 20 d: 1.225±1.095573406 (P<0.79) 
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Fig. 2: SDS-PAGE of NT3 gene expression in transgenic Leishmania on 3, 7, 10, 15 and 20 days after transfec-
tion. Wild-type as positive control (lane1), mutant strain in 20th (lane2), 15th (lane3), 10th (lane4), 7th (lane5), 3th (lane6) 
days after electroporation 
 
 
 
 
Fig. 3: Western blot analysis of NT3 gene expression in transgenic Leishmania on 3, 7, 10, 15 and 20 d after 
transfection. This result confirmed NT3 protein expression in the previous test. Total protein extracted from 
1×106 cells of wild-type promastigotes and transgenic promastigotes were electrophoresed and subjected to 
western blot analysis with anti NT3 Ab. NT3 protein is 54.6 KDa. Protein Marker (lane1), wild-type as posi-
tive control (lane2), mutant strain in 20th (lane3), 15th (lane4), 10th (lane5), 7th (lane6), 3th (lane7) d after elec-
troporation and NT3 construct as negative control (lane8). The result of this experiment shows that NT3 gene 
in transgenic Leishmania was expressed and the expression was too low 
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Macrophages infection 
The percentages of infected macrophages in 
contact with the mutant L. major and wild-type 
strain were evaluated after 24, 48 and 72 h. 
The infected macrophages with the mutant 
parasites at the three-time points were lower 
than that of the wild-type strain. The statistical 
analysis showed a significant difference 
(P<0.05) between percentages of the infected 
macrophages in the mutant L. major and the 
wild-type strains (Fig. 4). 
 
The number of amastigotes infected macro-
phages with transgenic L. major was lower than 
that of the wild-type strain. The statistical 
analysis showed a significant difference 
(P<0.05) between the number of amastigotes 
infected macrophages in the mutant L. major 
and the wild-type strains (Fig. 5). In the light 
microscopy analysis, no difference was found 
in the shape and size (by eyepiece micrometer) 
of amastigotes in the mutant parasite and 
wild-type strain.  
 
 
Fig. 4: Percent of infective macrophage in contact with the mutant type with NT3 Leishmania major and wild 
type. The percentages of infected macrophages in the mutant strains was 15 ± 7.07% (n=2), 27.5± 3.5% 
(n=2) and 32.5 ± 3.5% (n=2) at 24, 48 and 72 h, respectively. In contrast, the percentage of infected macro-
phages in the wild-type was 62.5± 3.5% (n=2), 75 ± 7.07% (n=2, and 85 ± 7.07% (n=2) at 24, 48 and 72 h, 
respectively 
 
 
 
Fig. 5: The number of amastigotes in macrophages infected with transgenic Leishmania major. The number of 
amastigotes in macrophages infected with transgenic L. major was 17.5±3.5 (n=2), 25±7.07 (n=2), and 
32.5±3.5 (n=2) in 24, 48 and 72 h, respectively; on the other hand, the number of amastigotes in the wild-type 
was 62.5±3.5 (n=2) in 24 h, 72.5±3.5 (n=2) in 48 h, and 80±0 (n=2) in 72 h 
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The lesions in BALB/c mice, created within 
30 d in the mice infected with the wild type 
(Fig. 6 A) but in the mice infected with mutant 
parasites any lesions were not created within 
30 d (Fig. 6 B). It was created within 70 d in 
the mice infected with mutant parasites (Fig. 6 
C,D within 70 d in the mice infected with the 
wild type). More than one ulcer with a diame-
ter greater than 5 mm were found in the mice 
receiving the wild type, while one ulcer with a 
diameter of less than 5 mm was observed in 
the mice infected with the mutant strain.
 
 
 
Fig. 6: Compare BALB/c mice infected lesions in wild type and transgenic parasites. The lesions were created 
within 30 d in the mice injected with wild type (B) and were not created within 30 d in the mice injected with 
mutant parasites (A). It was created during 70 d in the mice infected with mutant parasites (C, D lesions70 d 
in the mice infected with wild type). Many lesions were seen with a diameter of more than 5 mm in the mice 
infected with wild type. While, one lesion with a diameter of less than 5 mm was observed in the mice infected 
with the NT3 mutant strain 
 
Discussion 
 
In L. major, NT3 gene is the essential trans-
porter for purine nucleobases and it has many 
roles in the biology of L. major (14). In this 
study, antisense RNA was used to down-
regulating NT3 gene expression. Antisense 
RNA usually creates a barrier to the transmis-
sion of genetic information from RNA to pro-
teins (23). In this research, expression of this 
gene was evaluated after transfection with mu-
tant Leishmania in vitro and in vivo. 
Antisense has been effective on the expres-
sion of this gene since the tenth day. Although 
on the seventh day, there was a significant in-
crease in the expression of the gene (P<0.05), 
on the tenth day, the antisense had a signifi-
cant decreasing on the expression of the gene 
(P<0.05). Since the proliferation of pro-
mastigotes is performed on every 7 h, the anti-
sense effect is temporary so, parasites lose 
plasmid and normally express this gene. Con-
sequently, the gene expression from the tenth 
day shows an increasing trend.  
NT3 protein was down-regulated. Neverthe-
less, the NT3 protein with a molecular weight 
of 54.6 kDa was produced followed by gene 
expression. We evaluated the percentage of 
infected macrophage in murine macrophages 
J774 within 24, 48 and 72 h after electro-
poration of transgenic Leishmania pro-
mastigotes compared with wild-type parasites 
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of L. major promastigotes. There is the reduc-
tion of the infected macrophages and reduc-
tion in the number of amastigotes inside the 
infected macrophages with mutant Leishmania. 
On the other hand, in the infected macro-
phages with mutant Leishmania, there is re-
duced the ability of proliferation of parasites 
or virulence of parasites. Macrophages stimu-
late the cellular response and eventually elimi-
nate amastigotes inside the macrophages (24, 
25). In this study, size and number of ulcers in 
BALB/c mice were investigated in vivo. Size 
and number of ulcers in BALB/c mice infect-
ed with transgenic Leishmania promastigotes 
were less than the BALB/c mice infected with 
wild-type parasites. However, the incubation 
period of ulcers in BALB/c mice infected 
with transgenic Leishmania promastigotes was 
longer than the BALB/c mice infected with 
wild-type parasites. In this case, our results are 
agreement with the research of Mottram (26). 
Our results showed the reduction of the ex-
pression the gene and the virulence of para-
sites may be caused by antisense RNA.  
 
Conclusion 
 
We were able to temporarily downregulate 
gene expression of NT3. Further studies are 
required to provide new targets for interven-
tional therapy in Leishmania infection. 
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